Trump has repeatedly threatened to drastically slash NIH funding, but its new $37 billion budget is a historic high.
Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.
Following several Sync for Genes pilots, FHIR Genomics advocates are pushing for adoption of their standard to make omics data compatible with EHRs.
The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.
The health system has changed the way it offers patients pharmacogenomics and has mandated a new assessment in annual visits intended to identify patients eligible for other genetic tests.
The National Network of Libraries of Medicine will support community engagement efforts by public libraries across the US and help improve participant access.
The groups will receive a combined $1 million to spend on educating their communities about precision medicine and the benefits of participating in All of Us.
Geisinger is hoping to help others around the country implement precision medicine, which requires significant investment in genomics expertise, as well as infrastructural and operational changes.
Early users' experience engaging with the study protocol via the newly launched JoinAllofUs.org reveals areas that need refinement ahead of a full launch next year.
Spun out of Moffitt Cancer Center, M2Gen and the Total Cancer Care protocols promise rapid advancements in precision medicine, starting with oncology.
Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.
Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.
The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.
In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.